Il Dong Pharmaceutical Co Ltd (249420) — Cash Flow-to-Debt Ratio
Il Dong Pharmaceutical Co Ltd (249420) has a Cash Flow-to-Debt Ratio of 0.03x as of September 2025, meaning its operating cash flow of ₩11.28 Billion could theoretically repay 0% of its total liabilities (₩347.04 Billion) in one year. See 249420 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Il Dong Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2016–2024)
Historical debt coverage capacity for Il Dong Pharmaceutical Co Ltd across 9 annual periods. For the full cash flow conversion analysis, see Il Dong Pharmaceutical Co Ltd cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Il Dong Pharmaceutical Co Ltd (2016–2024)
Year-by-year debt coverage analysis for Il Dong Pharmaceutical Co Ltd. Check Il Dong Pharmaceutical Co Ltd (249420) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.07x | ₩28.29 Billion | ₩429.99 Billion | ▲ +178.5% |
| 2023 | -0.08x | ₩-36.62 Billion | ₩437.00 Billion | ▲ +28.4% |
| 2022 | -0.12x | ₩-53.54 Billion | ₩457.59 Billion | ▼ -464.5% |
| 2021 | -0.02x | ₩-11.37 Billion | ₩548.39 Billion | ▼ -137.5% |
| 2020 | 0.06x | ₩19.37 Billion | ₩350.73 Billion | ▼ -52.0% |
| 2019 | 0.11x | ₩41.37 Billion | ₩359.83 Billion | ▼ -50.3% |
| 2018 | 0.23x | ₩66.65 Billion | ₩287.84 Billion | ▼ -12.2% |
| 2017 | 0.26x | ₩73.72 Billion | ₩279.55 Billion | ▲ +61.7% |
| 2016 | 0.16x | ₩45.98 Billion | ₩281.94 Billion | — |